Pilot Randomised Controlled Trial of Posturing Following Surgery for Full-thickness Macular Hole
1 other identifier
interventional
30
1 country
1
Brief Summary
This is a pilot randomised controlled trial (RCT) to investigate the effect of postoperative face-down positioning on the outcome of macular hole surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for early_phase_1
Started Jan 2005
Longer than P75 for early_phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 21, 2010
CompletedFirst Posted
Study publicly available on registry
October 22, 2010
CompletedOctober 22, 2010
August 1, 2006
5.1 years
October 21, 2010
October 21, 2010
Conditions
Outcome Measures
Primary Outcomes (1)
Anatomical closure of the macula hole assessed 6 weeks following surgery by ocular coherence tomography.
6 weeks
Secondary Outcomes (1)
Visual acuity assessed 6 weeks following surgery by Snellen charts.
6 weeks
Study Arms (2)
Face-down posturing group
EXPERIMENTALPostoperative face-down positioning for 10 days after surgery.
Non-posturing group
ACTIVE COMPARATORavoid a face-up position for 10 days after surgery
Interventions
Postoperative face-down posturing for 10 days after surgery.
avoid a face-up position only for 10 days after surgery
Eligibility Criteria
You may qualify if:
- full thickness macular hole
- \>16 years old
You may not qualify if:
- any history of previous intraocular surgery (including cataract surgery)
- history of ocular trauma
- history of visual loss greater than 1 year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moorfileld's Eye Hospital
London, London, EC1V 2PD, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 21, 2010
First Posted
October 22, 2010
Study Start
January 1, 2005
Primary Completion
February 1, 2010
Study Completion
October 1, 2010
Last Updated
October 22, 2010
Record last verified: 2006-08